Angiosarcoma represents 1 to 2% of soft tissue tumors. It originates from endothelial cells of
small blood vessels and may affect a variety of organs, including the retroperitoneum …

Introduction Angiosarcoma is a rare soft tissue malignancy of endothelial cells, generally
associated with a poor prognosis. Due to its rarity, randomized trials are difficult to conduct …

PURPOSE Angiosarcoma is a rare vascular malignancy, and there are few published data
to guide chemotherapy treatment decisions. We present a retrospective analysis of …

10034 Background: Angiosarcoma is a rare vascular neoplasm that may arise in a variety of
anatomic locations. There is limited published data on chemotherapy treatment in …

Angiosarcoma is an uncommon tumor that presents in several scenarios. Although
angiosarcoma can occur in any organ, it typically presents in the following settings: 1) in the …

Background: Angiosarcomas (AS) are rare tumors of vascular origin with a variable behavior
and overall poor prognosis. We sought to assess the outcomes of patients treated for …

We propose a literature review of available data on angiosarcoma (AS). AS account for 1%
of adult soft tissue sarcoma. Two risk factors are well-establish chronic lymhoedema …

Objective: Angiosarcoma is an aggressive malignancy with endothelial differentiation and
notoriously poor prognosis despite aggressive therapy. Limited data are available to guide …

Background Angiosarcoma is a highly aggressive soft tissue sarcoma. Responses to
anthracyclines plus/minus ifosfamide, and taxanes alone or in combination with gemcitabine …

Background Angiosarcomas are rare tumors that carry poor prognosis. Because of insidious
growth rate, the diagnosis is often difficult and delayed. Methods Between 1990 and 2011 …